Form 4: Merck Director Mary Ellen Coe Reports Acquisition of Phantom Stock Units and Minor Common Stock Disposition

Merck & Co., Inc. Director Mary Ellen Coe reported the acquisition of 378.9793 phantom stock units and the disposition of 10 shares of common stock on June 30, 2025.

Summary

• Mary Ellen Coe, a Director of Merck & Co., Inc. [MRK], filed a Form 4 statement of changes in beneficial ownership.
• On June 30, 2025, Coe acquired 378.9793 phantom stock units at a price of $79.16 per unit.
• These phantom stock units are convertible 1-for-1 into common stock and are structured to be settled 100% in cash upon termination of service, in accordance with a distribution schedule elected under the Plan for Deferred Payment of Directors' Compensation.
• Following this transaction, Coe beneficially owns a total of 28,051.7533 phantom stock units.
• The reported holdings also include shares acquired through dividend reinvestment transactions.
• Additionally, the filing indicates a disposition of 10 shares of common stock on the same date.

Sentiment

Score: 6

Explanation: The filing indicates a director's acquisition of phantom stock units, which generally aligns interests with shareholders, offset by a very minor disposition of common stock. It's a routine compensation-related filing, not indicative of strong positive or negative sentiment regarding company performance.

Positives

• The acquisition of 378.9793 phantom stock units by a director indicates continued alignment of interests with shareholders, as the value of these units is tied to the company's stock performance.
• The phantom stock units were acquired at a specific price of $79.16 per unit, reflecting a valuation at the time of the transaction.
• The total beneficial ownership of 28,051.7533 phantom stock units demonstrates a significant stake held by the director, reinforcing long-term commitment.

Negatives

• A disposition of 10 shares of common stock by a director was reported, though this is a very small amount and may not be indicative of a negative outlook.

Risks

• Phantom stock units are settled in cash upon termination of service, meaning the director does not directly hold common stock for these units, which could limit direct exposure to stock price appreciation beyond the cash value.
• The value of the phantom stock units is directly tied to the common stock price, exposing the director to market fluctuations until the units are settled.

Future Outlook

The phantom stock units are structured to be settled 100% in cash upon the reporting person's termination of service, in accordance with a pre-elected distribution schedule under the Plan for Deferred Payment of Directors' Compensation.

Industry Context

This Form 4 filing reflects a routine insider transaction for a director at a major pharmaceutical company. Such transactions are common for executive and board compensation, often involving deferred compensation plans like phantom stock units, which align director interests with long-term company performance without direct equity ownership until settlement.

Comparison to Industry Standards

• The use of phantom stock units as part of director compensation is a common practice in the pharmaceutical and broader corporate sectors, aligning director incentives with shareholder value.
• Companies like Pfizer, Johnson & Johnson, and Novartis also utilize various forms of equity-linked compensation, including restricted stock units or phantom stock, to retain and incentivize their board members.
• The specific terms, such as cash settlement upon termination, are typical for deferred compensation plans designed for non-employee directors, ensuring long-term commitment and orderly transitions.

Stakeholder Impact

• Shareholders: The acquisition of phantom stock units by a director generally signals continued alignment of interests with shareholder value, as the value of these units is tied to the company's stock performance. The disposition of 10 shares is negligible.
• Employees: No direct impact is indicated by this filing.
• Customers: No direct impact is indicated by this filing.
• Suppliers: No direct impact is indicated by this filing.
• Creditors: No direct impact is indicated by this filing.

Next Steps

• The phantom stock units will be settled in cash upon the reporting person's termination of service, according to the elected distribution schedule.

Key Dates

Keywords

Merck & Co., MRK, SEC Form 4, Insider Transaction, Director Compensation, Phantom Stock, Equity Compensation, Stock Ownership, Mary Ellen Coe